Skip to main content
OpenTrials

Clinical trial condition

Dwarfism, Pituitary

Explore clinical trials studying Dwarfism, Pituitary. Study availability and eligibility vary by location and protocol.

192 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Dwarfism, Pituitary trial results

Completed

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

NCT00256126

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +30 more
Locations
  • Local Medical Information Office Buenos Aires, Argentina
  • Local Medical Information Office Sydney, Australia
  • Local Medical Information Office Vienna, Austria
  • Local Medical Information Office Mississauga, Canada
View all 13 locations
View Trial Details
Completed

Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype

NCT01616095

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • V th Internal Clinic, Univeristy Hospital Bratislava, Comenius University Bratislava, Slovakia
  • Inst. Exp. Endocrinology Slovak Acad Sci Bratislava, Slovakia
  • National Institute of Endocrinology and Diabetology Ľubochňa, Slovakia
View Trial Details
Completed

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

NCT02558829

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • Harbor UCLA Medical Center Torrance, California, United States
  • Texas Diabetes and Endocrinology Austin, Texas, United States
  • Baylor College of Medicine-Endocrinology Houston, Texas, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View all 27 locations
View Trial Details
Completed

An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)

NCT01806298

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +11 more
Locations
  • Research site Adelaide, South Australia, Australia
  • Research site Perth, Western Australia, Australia
  • Research site Clayton, Australia
  • Research site Darlinghurst, Australia
View all 19 locations
View Trial Details
Completed

Observational Prospective Study on Patients Treated With Norditropin®

NCT00960128

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +50 more
Locations
  • Novo Nordisk Investigational Site Prov. de Buenos Aires, Argentina
  • Novo Nordisk Investigational Site Brussels, Belgium
  • Novo Nordisk Investigational Site Prague, Czechia
  • Novo Nordisk Investigational Site Copenhagen S, Denmark
View all 23 locations
View Trial Details

Related conditions